DIRECTIONAL SIMULATION — NOT THE CFO FORECAST. For ELT what-if analysis only; AGP's AOP and the CFO forecast shown as benchmarks.
Levers
“Reproduce last year” sets all levers to neutral and bookings to zero, so the forecast equals the trailing twelve months exactly.
New BookingsGROSS · $000s
Estimated gross bookings by quarter
AOP: 3,543
AOP: 2,247
AOP: 2,043
AOP: n/a
Gross bookings$8,000K
Net ratio× 70.5%
Net bookings$5,641K
TTM actual (net) $4.58MTTM AOP (net) $6.50M-29.5%
Bookings spread
Lag (months)Cohort starts 2 months after close
Spread (months)Revenue spreads over 12 months
Upsell BookingsGROSS · $000s
Estimated gross bookings by quarter
AOP: 800
AOP: 800
AOP: 629
AOP: n/a
Gross bookings$2,000K
Net ratio× 70.5%
Net bookings$1,410K
TTM actual (net) $2.22MTTM AOP (net) $2.50M-11.1%
Bookings spread
Lag (months)Cohort starts 2 months after close
Spread (months)Revenue spreads over 12 months
Forward 12-month P&L — our forecast vs benchmarks
values in $000s
| Line item | May-26 | Jun-26 | Jul-26 | Aug-26 | Sep-26 | Oct-26 | Nov-26 | Dec-26 | Jan-27 | Feb-27 | Mar-27 | Apr-27 | Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Revenue | 4,213 | 4,844 | 4,697 | 6,353 | 6,252 | 6,828 | 6,958 | 6,854 | 4,428 | 5,222 | 6,319 | 5,906 | 68,873 |
| Net Revenue | 2,314 | 2,610 | 2,506 | 2,914 | 3,045 | 3,060 | 3,294 | 2,598 | 2,603 | 2,870 | 2,872 | 2,884 | 33,570 |
| Total COGS | 2,687 | 2,929 | 2,954 | 4,195 | 4,067 | 4,662 | 4,383 | 5,024 | 2,651 | 3,185 | 4,348 | 3,904 | 44,988 |
| Gross Profit | 1,527 | 1,915 | 1,743 | 2,158 | 2,186 | 2,166 | 2,575 | 1,829 | 1,777 | 2,037 | 1,971 | 2,002 | 23,885 |
| Payroll Expense | 1,350 | 1,392 | 1,298 | 1,313 | 1,260 | 1,228 | 1,445 | 1,391 | 1,483 | 1,472 | 1,352 | 1,431 | 16,415 |
| Total Operating Expenses | 1,822 | 1,764 | 1,817 | 1,897 | 1,711 | 1,564 | 1,898 | 1,747 | 1,913 | 1,865 | 1,769 | 1,914 | 21,684 |
| EBITDA | -255 | 192 | -34 | 302 | 515 | 643 | 718 | -92 | -109 | 193 | 224 | 110 | 2,407 |
Like-to-like comparison — full 12 months (real + estimated)
Like-to-like comparisonAOP · EBITDA
Jan–Apr 2027 are estimated. AOP ends Dec 2026, so those 4 months use AOP’s prior-year values as a placeholder. Both totals are shown below: real overlap (8 months) and full 12 months.
Monthly Δ (our forecast − AOP) · EBITDA
Gap narrows toward the end of the window. · * = estimated (prior-year proxy)
| Month | Forecast | AOP | Δ | Δ% |
|---|---|---|---|---|
| May-26 | -$254,566 | $73,293 | -$327,859 | -447.3% |
| Jun-26 | $191,654 | -$91,184 | $282,838 | -310.2% |
| Jul-26 | -$33,751 | $371,268 | -$405,019 | -109.1% |
| Aug-26 | $302,016 | $746,466 | -$444,450 | -59.5% |
| Sep-26 | $515,130 | $600,892 | -$85,761 | -14.3% |
| Oct-26 | $642,606 | $1,212,656 | -$570,050 | -47.0% |
| Nov-26 | $717,814 | $1,039,152 | -$321,338 | -30.9% |
| Dec-26 | -$91,535 | $588,008 | -$679,543 | -115.6% |
| Jan-27est. | -$108,867 | -$29,390 | -$79,477 | +270.4% |
| Feb-27est. | $193,184 | $316,943 | -$123,758 | -39.0% |
| Mar-27est. | $223,603 | $32,602 | $191,001 | +585.9% |
| Apr-27est. | $110,006 | $340,881 | -$230,874 | -67.7% |
| Real overlap total (8 mo) | $1,989,369 | $4,540,551 | -$2,551,182 | -56.2% |
| Full 12-mo total (incl. est.) | $2,407,295 | $5,201,585 | -$2,794,291 | -53.7% |